Terns Pharmaceuticals, Inc.
TERNDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted in 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Terns Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
TERN is no longer listed, and 13F filings after Q1 2026 list far fewer holders. See Q1 2026
- Institutional holders
- 1
- −312 vs. Q1 2026
- Shares held
- 1.42K
- −123.1M (−100.0%) vs. Q1 2026
- Total value
- $75.4K
- −$6.48B (−100.0%) vs. Q1 2026
- New holders
- 0
- 0 more added
- Sold out
- 312
- 0 more reduced
4 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $659.7K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $670.8M |
| Q2 2025 | 130 | $310.7M |
| Q1 2025 | 139 | $229.6M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.6M |
| Q2 2024 | 126 | $447.7M |
| Q1 2024 | 112 | $425.3M |
| Q4 2023 | 103 | $425.3M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.1M |
| Q1 2023 | 79 | $720.7M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.6M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| IFP Advisors, Inc | 1,424 | $75.4K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 0 | $0 | 0.00% | −9,569,585−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −6,449,140−100.0% | Sold out |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −5,695,000−100.0% | Sold out |
| Vanguard Capital Management LLC | 0 | $0 | 0.00% | −4,355,482−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −4,115,828−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −3,218,810−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −3,011,558−100.0% | Sold out |
| HBK Investments L P | 0 | $0 | 0.00% | −2,950,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −2,869,728−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −2,812,938−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −2,779,445−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −2,409,019−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −2,316,544−100.0% | Sold out |
| Glazer Capital, LLC | 0 | $0 | 0.00% | −2,295,498−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −2,216,499−100.0% | Sold out |
| Nearwater Capital Markets, Ltd | 0 | $0 | 0.00% | −2,150,400−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −2,139,662−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −2,124,817−100.0% | Sold out |
| Capitolis Liquid Global Markets LLC | 0 | $0 | 0.00% | −1,975,800−100.0% | Sold out |
| Acorn Capital Advisors, LLC | 0 | $0 | 0.00% | −1,746,264−100.0% | Sold out |
| Pictet Asset Management Holding SA | 0 | $0 | 0.00% | −1,655,575−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −1,456,378−100.0% | Sold out |
| Capital International Investors | 0 | $0 | 0.00% | −1,424,504−100.0% | Sold out |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −1,334,418−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −1,247,845−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,228,726−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −1,106,961−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −1,073,877−100.0% | Sold out |
| Whitebox Advisors LLC | 0 | $0 | 0.00% | −1,000,001−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −927,600−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −924,562−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −914,699−100.0% | Sold out |
| Highland Capital Management Fund Advisors, L.P. | 0 | $0 | 0.00% | −904,200−100.0% | Sold out |
| Vivaldi Asset Management, LLC | 0 | $0 | 0.00% | −904,161−100.0% | Sold out |
| Fort Baker Capital Management LP | 0 | $0 | 0.00% | −822,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −811,636−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −805,236−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −802,293−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −1,032,679−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −781,800−100.0% | Sold out |
| Nuveen, LLC | 0 | $0 | 0.00% | −772,592−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −747,377−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −725,000−100.0% | Sold out |
| Vanguard Portfolio Management LLC | 0 | $0 | 0.00% | −722,389−100.0% | Sold out |
| Fiera Capital Corp | 0 | $0 | 0.00% | −711,326−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −669,601−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −634,496−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −631,636−100.0% | Sold out |
| NEXTBio Capital Management LP | 0 | $0 | 0.00% | −604,534−100.0% | Sold out |
| Vanguard Fiduciary Trust Co | 0 | $0 | 0.00% | −573,997−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −562,631−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −557,361−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −537,884−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −530,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −521,571−100.0% | Sold out |
| Jones Hill Capital LP | 0 | $0 | 0.00% | −521,237−100.0% | Sold out |
| TIG Advisors, LLC | 0 | $0 | 0.00% | −511,191−100.0% | Sold out |
| Melqart Asset Management (UK) Ltd | 0 | $0 | 0.00% | −507,187−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −501,419−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −495,772−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −486,170−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −480,740−100.0% | Sold out |
| Beryl Capital Management LLC | 0 | $0 | 0.00% | −478,755−100.0% | Sold out |
| Samlyn Capital, LLC | 0 | $0 | 0.00% | −472,472−100.0% | Sold out |
| KVP Capital Advisors, LP | 0 | $0 | 0.00% | −440,000−100.0% | Sold out |
| Slotnik Capital, LLC | 0 | $0 | 0.00% | −420,700−100.0% | Sold out |
| Eagle Health Investments LP | 0 | $0 | 0.00% | −412,497−100.0% | Sold out |
| Catalio Capital Management, LP | 0 | $0 | 0.00% | −409,031−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −384,681−100.0% | Sold out |
| Sculptor Capital LP | 0 | $0 | 0.00% | −380,000−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −375,505−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −375,000−100.0% | Sold out |
| Boxer Capital Management, LLC | 0 | $0 | 0.00% | −375,000−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −360,878−100.0% | Sold out |
| First Turn Management, LLC | 0 | $0 | 0.00% | −326,694−100.0% | Sold out |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 0 | $0 | 0.00% | −321,905−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −312,181−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −311,623−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −304,487−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Atika Capital Management LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −299,199−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −295,622−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −284,931−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −281,667−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −281,614−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −275,350−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −271,857−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −267,520−100.0% | Sold out |
| Harvest Management LLC | 0 | $0 | 0.00% | −257,500−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −244,898−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −231,282−100.0% | Sold out |
| Absolute Gestao de Investimentos Ltda. | 0 | $0 | 0.00% | −230,000−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −205,700−100.0% | Sold out |
| Prosight Management, LP | 0 | $0 | 0.00% | −202,300−100.0% | Sold out |